ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Alfuzosine Uno Zentiva®:Helvepharm AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of informationPhoto 
G04CA01 - AlfuzosinATC-DDD Version 2016. Source: WHO
G - Genito Urinary System and Sex Hormones
 
G04 - Urologicals

Antiseptic and antiinfective preparations for systemic use specifically used in urinary tract infections, see J01.
Antiinfectives for systemic use, see group J.
Gynecological antiinfectives and antiseptics, see G01.

G04C - Drugs Used in Benign Prostatic Hypertrophy
 
G04CA - Alpha-Adrenoreceptor Antagonists

Alfuzosin and terazosin used in the management of urinary obstruction caused by benign prostatic hypertrophy, are classified here, while other alpha-adrenoreceptor blocking agents used both in the management of urinary obstruction and hypertension (e.g. doxazosin) are classified in C02CA.

G04CA01 - Alfuzosin
DoseRoute of administrationNote
 O 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home